FrancophonIA/ELRC3.0 huggingface dataset:
English: The proportion of subjects requiring treatment for a gout flare (APEX and FACT Study) was numerically lower in the groups that achieved an average post-baseline serum urate level <6.0 mg/dL, <5.0 mg/dL, or <4.0 mg/dL compared to the group that achieved an average postbaseline serum urate level ≥6.0 mg/dL during the last 32 weeks of the treatment period (Week 20-Week 24 to Week 49 - 52 intervals).
Maltese: Il-proporzjon ta' individwi li kellhom bżonn kura għall-irkadar tal-gotta (Studju APEX u FACT) kien numerikament aktar baxx fil-gruppi li laħqu livell medju ta' urate fis-serum wara l-linja bażi ta' <6.0 mg/dL, <5.0 mg/dL, jew <4.0 mg/dL meta mqabbel mal-grupp li laħaq livell medju ta' urate fisserum wara l-linja bażi ta' ≥6.0 mg/dL waqt l-aħħar 32 ġimgħa tal-perjodu ta' kura (intervalli Ġimgħa 20-Ġimgħa 24 sa Ġimgħa 49 - 52).
English: • increase in gout symptoms
Maltese: • żjieda fis-sintomi tal-gotta
English: (leukocytosis, with or without eosinophilia)
Maltese: (lewkoċiti, bi jew mingħajr eosinofilja)
English: Reduction in serum uric acid level to <6.0 mg/dL (357 µmol/L) was noted by the Week 2 visit and was maintained throughout treatment.
Maltese: Tnaqqis fil-livell ta' uric acid fis-serum għal <6.0 mg/dL (357 µmol/L) kien innutat maż-żjara ta' Ġimgħa 2 u kien miżmum tul il-kura.
English: • abnormal liver test results
Maltese: DATA TA' REVIŻJONI TAT-TEST
English: However, no clinically significant change in the percent decrease in serum uric acid concentration was observed where tested (80 mg multiple dose).
Maltese: Iżda ma kienet osservata l-ebda bidla ta' sinifikanza klinika fil-perċentwali ta' tnaqqis fil-konċentrazzjoni ta' uric acid fis-serum fejn ġie ttestjat (doża multipla ta' 80 mg).
English: Possible symptoms of allergic reactions might be: - rash including severe forms (e.g. blisters, nodules, itchy, exfoliative rash), itchiness - swelling of limbs or face - difficulties in breathing - fever with enlarged lymph nodes - but also serious life threatening allergic conditions with cardiac and circulatory arrest.
Maltese: Sintomi ta' reazzjonijiet allerġiċi li jista' jkun hemm jistgħu jinkludu: - raxx inklużi forom ħarxa (eż bżieżaq, noduli, raxx bil-ħakk, bil-qxur), ħakk - nefħa tar-riġlejn, dirgħajn jew wiċċ - tbatija biex tieħu n-nifs - deni bl-għenieqed limfatiċi minfuħa - iżda wkoll kondizzjonijiet allerġiċi li jistgħu jkunu ta' theddida għall-ħajja b'arrest kardijaku jew ċirkolatorju.
English: Tubulointerstitial nephritis*, micturition urgency
Maltese: Nefrite fit-tubuli tal-interstizzju*, urġenza biex tgħaddi l-awrina
English: Identified risk factors among these patients were a medical history of atherosclerotic disease and/or myocardial infarction, or of congestive heart failure.
Maltese: Fatturi ta' riskju li ġew identifikati fost dawn il-pazjenti kienu mard aterosklerotiku filpassat mediku u/jew infart mijokardijaku, jew insuffiċjenza tal-qalb konġestiva.
English: The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the RMP.
Maltese: L-MAH għandu jwettaq l-attivitajiet u l-interventi meħtieġa ta 'farmakoviġilanza dettaljati fl-RMP maqbul ippreżentat fil-Modulu 1.8.2 tal-Awtorizzazzjoni għat-Tqegħid fis-Suq u kwalunkwe aġġornament sussegwenti maqbul tal-RMP.
English: Caution is required when febuxostat is used in patients with alteration of thyroid function (see section 5.1).
Maltese: Attenzjoni hija meħtieġa meta febuxostat ikun użat f'pazjenti b'bidla fil-funzjoni tat-tirojde (ara sezzjoni 5.1).
English: The plasma protein binding of febuxostat is approximately 99.2%, (primarily to albumin), and is constant over the concentration range achieved with 80 and 120 mg doses.
Maltese: It-twaħħil mal-proteini fil-plażma ta' febuxostat huwa madwar 99.2%, (primarjament ma' albumin), u huwa kostanti fuq il-firxa ta' konċentrazzjoni miksuba b'dożi ta' 80 u 120 mg.
English: Thirst
Maltese: TLI
English: PHARMACEUTICAL PARTICULARS
Maltese: Kategorija farmakoterapewtika:
English: Uncommon Dyspnoea, bronchitis, upper respiratory tract infection, cough
Maltese: Qtugħ ta' nifs, bronkite, infezzjoni fil-passaġġ respiratorju ta' fuq, sogħla
English: Packaging
Maltese: Tiżmim
English: Content Package size
Maltese: Ippakkjar Kontenut Daqs talpakkett
English: Target species
Maltese: Perjodu ta'
English: 5 September 2013
Maltese: 5 ta' Settembru 2013
English: • organ transplantation.
Maltese: • trapjant tal-organi.
English: What is Okrido?
Maltese: X'inhu Okrido?
English: • allergies, including severe allergic reactions;
Maltese: • allerġiji, inkluż reazzjonijiet allerġiċi severi;
English: It is available as an oral solution (6mg/ml).
Maltese: Huwa disponibbli bħala soluzzjoni orali (6mg/ml).
English: • some cancers, including leukaemia, lymphoma and myeloma;
Maltese: • xi kanċers, inkluż lewkimja, limfoma u majeloma;
English: EMA/597611/2013
Maltese: 6 mg/ml) EMA/379127/2013
English: Okrido is a medicine that contains the active substance prednisolone sodium phosphate.
Maltese: Okrido huwa mediċina li fiha s-sustanza attiva prednisolone sodium phosphate.
English: The reference medicine was Prednisolone 5 mg soluble tablets by Sovereign.
Maltese: Il-mediċina ta' referenza kienet Prednisolone 5 mg pilloli solubbli minn Sovereign.
English: Why was Okrido reviewed?
Maltese: Għaliex ġie rivedut Okrido?
English: Okrido is a generic medicine based on a ‘reference medicine' already authorised in the EU.
Maltese: Okrido huwa mediċina ġenerika bbażata fuq ‘mediċina ta' referenza' diġà awtorizzata fl-UE.
English: The active substance in Okrido, prednisolone sodium phosphate, belongs to a group of medicines called glucocorticoids, which are substances that help to reduce inflammation.
Maltese: Is-sustanza attiva f'Okrido, prednisolone sodium phosphate, tagħmel parti minn grupp ta' mediċini msejħa glukokortikojdi, li huma sustanzi li jgħinu biex inaqqsu l-infjammazzjoni.
English: However, the Member States were not able to reach an agreement and the United Kingdom referred the matter to the CHMP for arbitration on 5 March 2013.
Maltese: Madankollu, l-Istati Membri ma setgħux jilħqu ftehim u r-Renju Unit irrefera l-kwistjoni lis-CHMP għal arbitraġġ fil-5 ta' Marzu 2013.
English: The grounds for the referral were that sufficient data had not been provided to show that Okrido produces comparable levels of the active substance in the body to Prednisolone 5 mg soluble tablets by Sovereign.
Maltese: Ir-raġunijiet għar-riferiment kienu li ma kinitx ġiet ipprovduta dejta suffiċjenti biex turi li Okrido jipproduċi livelli komparabbli tas-sustanza attiva fil-ġisem għal Prednisolone 5 mg pilloli solubbli minn Sovereign.
English: Pharmapol Arzneimittelvertrieb GmbH submitted Okrido for mutual recognition on the basis of the initial authorisation granted by the United Kingdom's Medicines and Healthcare products Regulatory Agency on 19 April 2010.
Maltese: Pharmapol Arzneimittelvertrieb GmbH issottomettiet lil Okrido għal rikonoxximent reċiproku abbażi talawtorizzazzjoni inizjali li ngħatat mill-Aġenzija Regolatorja tal-Mediċini u l-Prodotti tal-Kura tas-Saħħa tar-Renju Unit fid-19 ta' April 2010.
English: • skin conditions;
Maltese: • kundizzjonijiet tal-ġilda;
English: • diseases of the lungs (including asthma), upper airways (croup), blood vessels and heart, bowel or kidneys, muscles and joints (including rheumatoid arthritis) or the eye or nervous system;
Maltese: • Mard tal-pulmun (inkluż ażżma), tal-passaġġi ta' fuq tal-arja (krupp), tal-vażi tad-demm u tal-qalb,
English: On 27 June 2013, the European Medicines Agency completed an arbitration procedure following a disagreement among Member States of the European Union (EU) regarding the authorisation of the medicine Okrido.
Maltese: Fis-27 ta' Ġunju 2013, l-Aġenzija Ewropea għall-Mediċini temmet proċedura ta' arbitraġġ wara nuqqas ta' qbil fost l-Istati Membri tal-Unjoni Ewropea (UE) dwar l-awtorizzazzjoni tal-mediċina Okrido.
English: Based on an evaluation of the currently available data and the scientific discussion within the Committee, the CHMP concluded that, based on the data submitted, Okrido is expected to produce comparable levels of the active substance in the body to the reference medicine.
Maltese: Abbażi tal-valutazzjoni tad-dejta attwalment disponibbli u d-diskussjoni xjentifika fi ħdan il-Kumitat, isCHMP ikkonkluda li, abbażi tad-dejta sottomessa, Okrido huwa mistenni jipproduċi livelli komparabbli tas-sustanza attiva fil-ġisem għall-mediċina ta' referenza.
English: Okrido is used to treat a range of inflammatory and auto-immune conditions (diseases caused by the body's own defence system attacking normal tissue) including:
Maltese: tal-imsaren jew tal-kliewi, tal-muskoli u l-ġogi (inkluż artrite rewmatika) jew tal-għajnejn jew tas sistema nervuża;
English: Further information on Metacam can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: This summary was last updated in March 2018.
Maltese: Dan is-sommarju ġie aġġornat l-aħħar f'Marzu 2018.
English: Metacam contains the active substance meloxicam.
Maltese: Metacam fih is-sustanza attiva meloxicam.
English: Other information about Metacam
Maltese: Informazzjoni oħra dwar Metacam
English: 46 cats received Metacam oral suspension for 28 days whilst 48 cats received placebo oral suspension.
Maltese: 46 qattus irċevew sospensjoni orali ta' Metacam għal 28 jum filwaqt li 48 qattus irċevew sospensjoni orali bi plaċebo.
English: For the 20 mg/ml and 40 mg/ml solution for injection the meat withdrawal period is 5 days and for the 15 mg/ml oral suspension it is 3 days.
Maltese: Għas-soluzzjoni għall-injezzjoni ta' 20 mg/ml u ta' 40 mg/ml, il-perjodu ta' tiżmim għal-laħam huwa ħamest ijiem u għas-sospensjoni orali ta' 15 mg/ml il-perjodu huwa tlett ijiem.
English: What are the risks associated with Metacam?
Maltese: X'inhuma r-riskji assoċjati ma' Metacam?
English: In pigs, Metacam is used in non-infectious locomotor disorders (diseases that affect the ability to move) to reduce lameness and inflammation, relieve post-operative pain associated with minor soft tissue surgery such as castration, and for supportive therapy together with antibiotics in the treatment of diseases that occur after farrowing (giving birth) such as puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome, a bacterial infection of the udder and/or the womb).
Maltese: Fil-majjali, Metacam jintuża f'disturbi lokomotorji mhux infettivi (mard li jaffettwa l-ħila taċ-ċaqliq) għat-tnaqqis tas-sintomi ta' zappip u infjammazzjoni, għat-taffija tal-uġigħ ta' wara operazzjoni assoċjat ma' interventi kirurġiċi minuri fuq it-tessut artab bħal kastrazzjoni, u bħala terapija ta' appoġġ flimkien mal-antibijotiċi fil-kura ta' mard li jiżviluppa wara t-tifrigħ (il-ħlas) bħal settiċemija u tossemija puwerperali (sindromu ta' mastite-metrite-agalassija, infezzjoni batterika tal-beżżula u/jew tal-utru).
English: 326 cattle received Metacam given as an injection together with antibiotic therapy whilst 326 cattle received a placebo (dummy) injection and antibiotic therapy.
Maltese: 326 frat irċevew Metacam li ngħata bħala injezzjoni flimkien ma' terapija antibijotika filwaqt li 326 frat irċevew injezzjoni plaċebo (finta) u terapija antibijotika.
English: A study in 187 sows with puerperal septicaemia and toxaemia compared Metacam with flunixin (another NSAID).
Maltese: Studju fuq 187 majjal mara b'settiċemija u tossemija puwerperali qabbel Metacam ma' flunixin (NSAID ieħor).
English: Metacam received a marketing authorisation valid throughout the EU for Metacam on 7 January 1998.
Maltese: Metacam ingħata awtorizzazzjoni għat-tqegħid fis-suq valida fl-UE kollha fis-7 ta' Jannar 1998.
English: Guinea pigs treated with Metacam had significantly higher frequency of feed intake (240 events) over three days, indicating that their pain was reduced, compared with guinea pigs given placebo (207 events).
Maltese: Il-fniek tal-Indi li ngħataw kura b'Metacam kellhom frekwenza konsiderevolment ogħla ta' konsum ta' għalf (240 avveniment) fuq perjodu ta' tlett ijiem, li jindika tnaqqis fl-uġigħ tagħhom, meta mqabbla ma' fniek tal-Indi li ngħataw plaċebo (207 avvenimenti).
English: 37 cats received Metacam and 39 cats received carprofen (another NSAID) by subcutaneous (under the skin) injection immediately after receiving anaesthesia.
Maltese: 37 qattus irċevew Metacam filwaqt li 39 qattus irċevew carprofen (NSAID ieħor) permezz ta' injezzjoni subkutanja (taħt il-ġilda) immedjatament wara li ngħataw anestesija.
English: The effectiveness of Metacam injection was studied in 209 pigs with non-infectious locomotor disorders.
Maltese: L-effikaċja tal-injezzjoni ta' Metacam ġiet studjata fuq 209 majjal b'disturbi lokomotorji mhux infettivi.
English: Metacam improved lameness in horses at day 14 and at the final follow-up examination 2-4 days later than the vedaprofen treated group whilst the second study showed Metacam to be comparable to vedaprofen.
Maltese: Metacam tejjeb is-sintomi ta' zappip fiżżwiemel fl-14-il jum u fl-eżaminazzjoni ta' segwitu finali 2-4 ijiem wara fil-grupp li kien ingħata kura b'vedaprofen filwaqt li t-tieni studju wera li Metacam kien komparabbli ma' vedaprofen.
English: Metacam injection was studied in 60 calves with one group receiving Metacam and local anaesthetic and one group receiving a placebo injection and local anaesthetic prior to dehorning.
Maltese: L-injezzjoni ta' Metacam ġiet studjata fuq 60 għoġol bi grupp wieħed jirċievi Metacam u anestetiku lokali u grupp ieħor jirċievi injezzjoni plaċebo u anestetiku lokali qabel proċedura ta' tneħħija talqrejjen.
English: Cats
Maltese: Qtates
English: Metacam injection in combination with antibiotic therapy was investigated in a study involving 240 cattle with acute mastitis.
Maltese: L-injezzjoni ta' Metacam flimkien ma' terapija antibijotika ġiet investigata fi studju li fih ħadu sehem 240 frat b'mastite akuta.
English: Another study in cattle involved 501 calves with diarrhoea.
Maltese: Studju ieħor fuq il-frat kien jinkludi 501 għoġol bid-dijarea.
English: Metacam significantly reduced lameness with 49% of the Metacam treated pigs with no lameness compared with 27% of the pigs which received the placebo treatment.
Maltese: Metacam naqqas b'mod sinifikanti z-zappip b'49% tal-majjali li ngħataw kura b'Metacam b'ebda sinjali ta' zappip meta mqabbla ma' 27% tal-majjali li kienu ngħataw il-kura bi plaċebo.
English: All calves were given oral rehydration therapy and antibiotics.
Maltese: L-għoġġiela kollha ngħataw kura orali ta' reidratazzjoni u antibijotiċi.
English: A study was also carried out in cats with chronic musculo-skeletal disorders.
Maltese: Sar ukoll studju fuq qtates b'disturbi muskoloskeletali kroniċi.
English: The studies with chronic locomotor disorders showed Metacam to be effective.
Maltese: L-istudji f'disturbi lokomotorji kroniċi wrew li Metacam kien effettiv.
English: In one study three different meloxicam treatment schedules for acute locomotor disorders were compared.
Maltese: Fi studju wieħed, tqabblu tliet skedi differenti ta' kura b'meloxicam għal disturbi lokomotorji akuti.
English: In very rare cases, in dogs, haemorrhagic diarrhoea (bloody diarrhoea), haematemesis (vomiting blood) or gastrointestinal ulceration (ulcer in the gut) have been reported.
Maltese: F'każijiet rari ħafna, fil-klieb, ġew irrapportati dijarea emorraġika (dijarea bid-demm), ematemesi (rimettar tad-demm) jew ulċeri gastrointestinali (ulċeri fl-imsaren).
English: In very rare cases loss of appetite, lethargy, abdominal pain and colitis (inflammation of the lower part of the gut) have been reported.
Maltese: F'każijiet rari ħafna ġew irrapportati telf ta' aptit, letarġija, uġigħ addominali u kolite (infjammazzjoni tal-parti ta' isfel tal-imsaren).
English: Metacam was effective in improving mobility and reducing pain from day 0-14 compared to the control group.
Maltese: Metacam kien effettiv fit-titjib tal-mobbiltà u fit-tnaqqis tal-uġigħ mill-jum 0-14 meta mqabbel mal-grupp ta' kontroll.
English: A study was carried out in cats with acute musculo-skeletal disorders.
Maltese: Twettaq studju fuq qtates li kellhom disturbi muskoluskeletali akuti.
English: Metacam oral suspension was given for 5 days and compared with ketoprofen (another NSAID).
Maltese: Is-sospensjoni orali ta' Metacam ingħatat għal ħamest ijiem u tqabblet ma' ketoprofen (NSAID ieħor).
English: Metacam 5 mg/ml solution for injection was comparable to carprofen in reducing post-operative pain in cats following ovariohysterectomy.
Maltese: Issoluzzjoni għall-injezzjoni ta' 5 mg/ml ta' Metacam kienet komparabbli ma' carprofen fit-tnaqqis taluġigħ wara intervent kirurġiku fil-qtates wara li saritilhom ovarjoisterektomija.
English: The effectiveness of Metacam injection, in combination with antibiotic therapy, was studied in cattle with acute respiratory infection.
Maltese: L-effikaċja tal-injezzjoni b'Metacam, flimkien ma' terapija antibijotika, ġiet studjata fil-frat b'infezzjoni respiratorja akuta.
English: In dogs and cats, occasional side effects of Metacam are those seen with NSAIDs, such as loss of appetite, vomiting, diarrhoea, blood appearing in the stools, apathy (lack of vitality) and kidney failure.
Maltese: Fil-klieb u fil-qtates, l-effetti sekondarji li xi kultant ikun hemm bl-użu ta' Metacam huma dawk li jidhru bl-NSAIDs, bħal telf ta' aptit, rimettar, dijarea, demm fl-ippurgar, apatija (nuqqas ta' vitalità) u insuffiċjenza tal-kliewi.
English: Metacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.
Maltese: Metacam huwa mediċina antiinfjammatorja li tintuża fil-frat, il-majjali, iż-żwiemel, il-klieb, il-qtates u fil-fniek tal-Indi.
English: A laboratory study in 30 guinea pigs compared Metacam oral suspension with placebo given about 45 minutes before surgical castration and on each of the following two days.
Maltese: Studju tal-laboratorju fuq 30 fenek tal-Indi qabbel is-sospensjoni orali ta' Metacam ma' plaċebo mogħti madwar tliet kwarti qabel kastrazzjoni kirurġika u fil-jumejn segwenti.
English: In addition to antibiotic therapy animals either received a single injection of Metacam or flunixin (another NSAID) for up to 5 days.
Maltese: Minbarra t-terapija antibijotika l-annimali rċevew injezzjoni unika ta' Metacam jew flunixin (NSAID ieħor) sa ħamest ijiem.
English: As prostaglandins are substances that trigger inflammation, pain, exudation (fluid that leaks out of blood vessels during an inflammation) and fever, meloxicam reduces these signs of disease.
Maltese: Peress li l-prostaglandini huma sustanzi li jiskattaw l-infjammazzjoni, l-uġigħ, l-essudazzjoni (fluwidu li jnixxi mill-vażi tad-demm waqt infjammazzjoni) u d-deni, meloxicam inaqqas dawn is-sinjali tal-marda.
English: How does Metacam work?
Maltese: Kif jaħdem Metacam?
English: Guinea pigs
Maltese: Ħnieżer
English: In cattle, Metacam is used together with antibiotics, to reduce clinical signs such as fever and inflammation in acute (short-term) respiratory infection (infection of the lungs and airways).
Maltese: Fil-frat, Metacam jintuża flimkien mal-antibijotiċi, biex inaqqas sinjali kliniċi bħad-deni u linfjammazzjoni f'infezzjonijiet respiratorji (infjammazzjonijiet tal-pulmun u tal-passaġġi tal-arja) akuti (fuq perjodu qasir).
English: Horses
Maltese: Majjali
English: In dogs, Metacam is used to reduce post-operative pain and inflammation following orthopaedic (e.g. fracture operation) and soft tissue surgery.
Maltese: Fil-klieb, Metacam jintuża għat-tnaqqis tal-uġigħ u tal-infjammazzjoni wara intervent kirurġiku ortopediku (eż. operazzjoni fuq ksur) u fuq it-tessut artab.
English: In cattle and pigs, Metacam is well tolerated; only a slight temporary swelling at the injection site following subcutaneous administration was observed in most cattle studied in laboratory conditions.
Maltese: Fil-frat u fil-majjali, Metacam huwa ttollerat tajjeb; ġiet osservata biss nefħa temporanja żgħira fis-sit tal-injezzjoni wara l-għoti minn taħt il-ġilda fil-biċċa l-kbira tal-frat li ġew mistħarrġa taħt kondizzjonijiet fil-laboratorju.
English: In cats, Metacam is used to reduce post-operative pain and inflammation after ovariohysterectomy (spay operation), orthopaedic and minor soft tissue surgery.
Maltese: Fil-qtates, Metacam jintuża għat-tnaqqis tal-uġigħ u tal-infjammazzjoni wara intervent kirurġiku ta' ovarjoisterektomija (operazzjoni ta' sterilizzazzjoni), wara interventi kirurġiċi ortopediċi u fuq it-tessut artab.
English: People who are hypersensitive (allergic) to NSAIDs should avoid contact with Metacam.
Maltese: Il-persuni ipersensittivi (allerġiċi) għall-NSAIDs għandhom jevitaw kull kuntatt ma' Metacam.
English: A study in 150 piglets was carried out to compare the effects of Metacam injection with placebo when given before castration.
Maltese: Sar studju fuq 150 qażquż sabiex jitqabblu l-effetti ta' injezzjoni ta' Metacam mal-plaċebo meta tingħata qabel il-kastrazzjoni.
English: Metacam injection in cattle significantly improved clinical signs of respiratory infection and reduced fever compared with antibiotics alone.
Maltese: L-injezzjoni ta' Metacam fil-frat tejbet b'mod sinifikanti s-sintomi kliniċi tal-infezzjoni respiratorja u naqqset id-deni meta mqabbel ma' antibijotiċi weħidhom.
English: Metacam treated piglets had significantly reduced blood cortisol levels (which indicates that they were exposed to lower levels of stress) 30 minutes after castration compared with the control group.
Maltese: Il-qżieqeż li ngħataw kura b'Metacam kellhom livelli sinfikantement inqas ta' kortisol fid-demm (li jindika li kienu esposti għal livelli aktar baxxi ta' stress) nofs siegħa wara l-kastrazzjoni meta mqabbla mal-grupp ta' kontroll.
English: Metacam was comparable to flunixin in treating signs of infection and inflammation associated with puerperal septicaemia and toxaemia.
Maltese: Metacam kien komparabbli ma' flunixin fil-kura ta' sinjali ta' infezzjoni u infjammazzjoni assoċjati ma' settiċemija puwerperali u tossemija.
English: Pigs
Maltese: Klieb
English: Meloxicam acts by blocking an enzyme called cyclooxygenase which is involved in the production of prostaglandins.
Maltese: F'każijiet rari ħafna ġew irrapportati reazzjonijiet anafilattojdi u livelli għoljin ta' enzimi fil-fwied.
English: Ministry of Agriculture, Natural Resources and Environment
Maltese: Ministry of Agriculture, Natural Resources u Environment
English: Probability of approval (%)
Maltese: Probabbilta' ta' approvazzjoni (%)
English: 2.10 Parallel distribution
Maltese: 2.10 Distribuzzjoni parallela
English: IQM adviser:
Maltese: Konsulenta IQM:
English: Annex II to Note for guidance on process validation: non-standard processes
Maltese: Anness II to Note for guidance on process validation: non-standard processes
English: Swedish Orphan International AB
Maltese: Swedish Orfni International AB
English: An EU veterinary suspected adverse reaction report form for veterinarians and health professionals
Maltese: An UE veterinary suspected adverse reaction report form for veterinarians and health professionals
English: Orphan Europe SARL
Maltese: Orfni Europe SARL
English: Personnel and budget
Maltese: Personal u budget
English: Treatment of stress urinary incontinence in women
Maltese: Pending Treatment of stress urinary incontinence in women
English: Transparency
Maltese: Trasparenza
English: Geographical distribution at EMEA - 31 December 2004
Maltese: Distribuzzjoni geografika ta' l-EMEA - 31 ta' Dicembru 2004
English: Homoharringtonine Stragen France SAS
Maltese: Homoharringtonine Stragen Franza SAS
English: Head of Veterinary Medicinal Product Unit Ministry for Food, Agriculture and Fisheries Albertown
Maltese: Head of Veterinary Medicinal Product Unit Ministry for Food, Agriculture u Fisheries Albertown
English: Position paper on the data requirements for removing the target animal batch safety test for immunological veterinary medicinal products in the EU
Maltese: Position paper on the data requirements for removing the target animal batch safety test for immunological veterinary medicinal products in the UE